g class="alignleft" src="https://www.marketbeat.com/logos/articles/small_Depositphotos_72233795_s-2019.jpg" alt="3 Strong Buy-the-Dip Candidates in a Volatile Market" width="660" height="549" />There are plenty of people out there that always say “I’m waiting for a big market dip to get fully invested in the market”, yet when the dip actually occurs, they lack the confidence and plan of attack to take advantage of lower prices. Instead of sitting idly by while some of the best companies in the world go on sale, it can really pay off to use market weakness to your advantage. Buying the dip is known to be a very successful strategy over the long term, particularly when you use it in tandem with concepts like dollar-cost averaging. However, if you don’t have conviction and an idea of which names you would like to add during market corrections, it’s quite intimidating to actually execute during periods of volatility. Before you consider Edwards Lifesciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Edwards Lifesciences wasn't on the list.
While Edwards Lifesciences currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.